Alembic Pharma gets USFDA nod for generic drug to treat depression, anxiety

Alembic Pharmaceuticals Ltd. announced it has secured final approval from the USFDA for its generic Paroxetine extended-release tablets, available in 25 mg and 37.5 mg strengths. These tablets are therapeutically equivalent to Apotex Inc's Paxil CR and indicated for treating major depressive disorder, panic disorder, social anxiety disorder, and premenstrual dysphoric disorder.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/hfOoZ9A
via IFTTT